UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2020-03, Vol.72 (3), p.465-476

2020

Volltextzugriff (PDF)

Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2014-06, Vol.66 (6), p.1625-1635

2014

Volltextzugriff (PDF)

Pathogenesis of systemic sclerosis associated interstitial lung disease

Journal of scleroderma and related disorders, 2020-03, Vol.5 (2_suppl), p.6-16

2020

Volltextzugriff (PDF)

Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort

Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.472-481

2024

Volltextzugriff (PDF)

High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis

Rheumatology (Oxford, England), 2021-02, Vol.60 (2), p.849-854

2021

Volltextzugriff (PDF)

Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis

Rheumatology (Oxford, England), 2022-02, Vol.61 (2), p.781-786

2022

Volltextzugriff (PDF)

Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis

Arthritis & rheumatology (Hoboken, N.J.), 2023-03, Vol.75 (3), p.449-458

2023

Volltextzugriff (PDF)

Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis

Journal of rheumatology, 2020-11, Vol.47 (11), p.1668-1677

2020

Volltextzugriff (PDF)

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

Annals of the rheumatic diseases, 2012-07, Vol.71 (7), p.1235-1242

2012

Volltextzugriff (PDF)

Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis

Rheumatology (Oxford, England), 2016-01, Vol.55 (1), p.115-119

2016

Volltextzugriff (PDF)

Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time

Journal of rheumatology, 2017-04, Vol.44 (4), p.404-406

2017

Volltextzugriff (PDF)

Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis

Rheumatology (Oxford, England), 2022-05, Vol.61 (5), p.1948-1956

2022

Volltextzugriff (PDF)

Characteristics and Survival of Anti–U1 RNP Antibody–Positive Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Arthritis & rheumatology (Hoboken, N.J.), 2016-02, Vol.68 (2), p.484-493

2016

Volltextzugriff (PDF)

Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors

Rheumatology (Oxford, England), 2013-10, Vol.52 (10), p.1824-1831

2013

Volltextzugriff (PDF)

Autoantibodies as predictive tools in systemic sclerosis

Nature reviews. Rheumatology, 2010-02, Vol.6 (2), p.112-116

2010

Volltextzugriff (PDF)

Clinical and serological hallmarks of systemic sclerosis overlap syndromes

Journal of rheumatology, 2011-11, Vol.38 (11), p.2406-2409

2011

Volltextzugriff (PDF)

Resolution of paraneoplastic PM/Scl-positive systemic sclerosis after curative resection of a pancreatic tumour

Rheumatology (Oxford, England), 2017-02, Vol.56 (2), p.317-318

2017

Volltextzugriff (PDF)

Derivation and External Validation of a Prediction Rule for Five‐Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.993-1003

2016

Volltextzugriff (PDF)

Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis

Rheumatology (Oxford, England), 2016-01, Vol.55 (1), p.115-119

2016

Volltextzugriff (PDF)

Derivation and Validation of a Prediction Rule for Two‐Year Mortality in Early Diffuse Cutaneous Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2014-06, Vol.66 (6), p.1616-1624

2014

Volltextzugriff (PDF)

Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort

Journal of rheumatology, 2010-11, Vol.37 (11), p.2422-2426

2010

Volltextzugriff (PDF)

Autologous HSCT for systemic sclerosis

The Lancet (British edition), 2013-06, Vol.381 (9883), p.2079-2080

2013

Volltextzugriff (PDF)

Defining genetic risk factors for scleroderma-associated interstitial lung disease

Clinical rheumatology, 2020-04, Vol.39 (4), p.1173-1179

2020

Volltextzugriff (PDF)

Impact of Hallmark Autoantibody Reactivity on Early Diagnosis in Scleroderma

Clinical reviews in allergy & immunology, 2012-12, Vol.43 (3), p.249-255

2012

Volltextzugriff (PDF)

Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis

Rheumatology advances in practice, 2018-01, Vol.2 (1), p.rky002-rky002

2018

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Rheumatology
(29)
Humans
(26)
Male
(19)
Female
(18)
Systemic Sclerosis
(18)
Scleroderma
(17)
Middle Aged
(12)
Adult
(10)
Scleroderma, Systemic - Complications
(9)
Cohort Studies
(8)
Scleroderma, Systemic - Immunology
(8)
Autoantibodies
(7)
Prognosis
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Aged
(5)
Diseases Of The Osteoarticular System
(5)
Health Risk Assessment
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis

Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

Pathogenesis of systemic sclerosis associated interstitial lung disease

Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort

High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis

Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis

Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis

Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis

Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time

Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis

Characteristics and Survival of Anti–U1 RNP Antibody–Positive Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors

Autoantibodies as predictive tools in systemic sclerosis

Clinical and serological hallmarks of systemic sclerosis overlap syndromes

Resolution of paraneoplastic PM/Scl-positive systemic sclerosis after curative resection of a pancreatic tumour

Derivation and External Validation of a Prediction Rule for Five‐Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis

Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis

Derivation and Validation of a Prediction Rule for Two‐Year Mortality in Early Diffuse Cutaneous Systemic Sclerosis

Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort

Autologous HSCT for systemic sclerosis

Defining genetic risk factors for scleroderma-associated interstitial lung disease

Impact of Hallmark Autoantibody Reactivity on Early Diagnosis in Scleroderma

Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis

Suchergebnisse filtern